Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
TipRanks on MSN
Propanc Biopharma requests foreign filing license from Spain
Propanc Biopharma (PPCB) submitted a request for a foreign filing license from Spain for two provisional patents detailing new methods to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback